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The antimicrobial activity of methanol extract of Triumfetta rhomboidea leaves was evaluated against 
Staphylococcus aureus, Salmonella typhi and Klebsiella pneumoniae. Agar diffusion and agar dilution 
techniques were employed for the antimicrobial sensitivity and interaction studies. Phytochemical analysis of 
the crude extract was also carried out using standard procedures. The results obtained showed that the crude 
extract exhibits a substantial antimicrobial activity against Klebsiella pneumoniae (which recorded the greatest 
sensitivity), Salmonella typhi but not against Staphylococcus aureus. The result of the interactive studies 
between the crude extract and standard antibiotics showed relationship ranging from antagonism to synergy. 
Phytochemical analysis revealed the presence of terpen s, flavonoids and other phenolics and resins in the 
crude extract. Thus, this study shows that Triumfetta rhomboidea possesses promising antimicrobial activity 
especially against Klebsiella pneumoniae. 
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Many infective diseases are treated 
with chemotherapeutic agent, such as 
antibiotics, that selectively inhibit or kill the 
pathogen with little or no effect on the host. 
Ideally, antimicrobial agents disrupt microbial 
processes or structures that differ from those 
of the host. They may damage pathogen by 
hampering cell wall synthesis, inhibiting 
microbial protein and nucleic acid synthesis, 
disrupting microbial membrane structure and 
function or blocking metabolic pathways 
through the inhibition of key enzymes 
(Prescott et al., 2008). The conventional 
antimicrobial agents face a lot of resistant 
problems in recent times as microorganisms 
are loosing sensitivity to some of these drugs. 
Recently, concern has been expressed about 
the rising prevalence of pathogenic 
microorganisms which are resistant to the old 
generation, and to the newer or modern 
antibiotics that have been produced in the last 
decades (Cohen, 1992; Nascimento et al., 
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2000; Okesola and Makanjuola, 2009). Also 
the problem posed by the high cost; 
adulteration and increasing toxic side effects 
of these synthetic drugs coupled with their 
relative inadequacies in disease treatment 
especially in the developing countries portend 
serious limitations (Shariff, 2001). 
Consequently, the continuous acute need of 
novel and effective antibiotics for 
antimicrobial chemotherapy is clearly evident.  
Phytochemicals derived from plants 
have shown great promise in the treatment of 
intractable infectious diseases (Nascimento et 
al., 2000; Rios and Recio, 2005) with lesser 
side effects compared to the synthetic drug 
agent (Iwu et al., 1999). In traditional herbal 
practice, indigenous medicinal plants have 
been employed in the treatment of several 
important infections (Fennell et al., 2004, 
Taylor et al., 2001). Also, plant-based 
extractives have equally served as source of 
lead compounds for further developments of 
future antimicrobial agents. Therefore, 
evaluation of a candidate medicinal plant may 
lead to identification of very effective herbal 
antimicrobial treatments or provide leads for 
further development into novel antimicrobial 
agents. 
 Triumfetta rhomboidea Jacq (Family: 
Tiliaceae) is an under shrub, widely 
distributed in tropical and subtropical India, 
Ceylon, Malay Peninsula, China, Africa and 
in America (Sivakumar et al., 2010). It is a 
perennial herb having important roles in 
ancient therapy. Various Parts of the plant 
used therapeutically are fruit, flower, leaves, 
bark and roots. The root is tonic styptic, 
galactogogue, aphrodisiac, cooling, useful in 
dysentery and as diuretic. Pounded roots are 
given in the treatment of intestinal ulcer. 
Leaves, flowers and fruit are mucilaginous 
demulcent, astringent, and also used in 
gonorrhoea and against leprosy (Barnes, 2002; 
Chattergee and Chandra, 1992; Chopra et al., 
1986; Mukharjee, 2002).  
Presently, there is very limited data on 
the scientific basis for antimicrobial utility of 
the leaf extract from Triumfetta rhomboidea. 
This study therefore, was carried out to 
evaluate the antimicrobial activity of its 
methanol extract against certain bacterial 
isolates.  
 
MATERIALS AND METHODS 
Collection of plant material 
The leaves of Triumfetta rhomboidea 
were collected from Nsukka Enugu state. The 
plant was authenticated by Mr. H. Ozioko of 
the Center of Bioresearch (BDCP) Nsukka. A 
voucher specimen (UPH 570) was deposited 
in the herbarium of the Department of Botany, 
University of Port Harcourt, Port Harcourt. 
 
Test microorganisms 
The organisms used for this study 
included clinical isolates of Staphylococcus 
aureus, Klebsiella pneumoniae, and 
Salmonella typhi obtained from the 
Pharmaceutical Microbiology Laboratory, 
University of Nigeria Nsukka. Identification 
of bacterial isolates was performed according 
to standard bacteriological techniques 
previously established (Baron and Finegold, 
1990; Cowan et al., 1993). 
 
Drugs and reagents 
The following materials were used in 
the study, methanol (Fluka, Germany), 
nutrient agar (Oxoid), discs antibiotics: 
amoxicillin 25µg, augmentin 30µg, 
nitrofurantoin 300µg, gentamicin 10µg, 
nalidixic acid 30µg, ofloxacin 30µg, 
cotrimoxazole 25µg, tetracycline 30µg 
(Oxoid). 
 
Antimicrobial activity of the crude extract 
of Triumfetta rhomboidea on the test 
bacteria 
The antimicrobial sensitivity test was 
conducted using a modification of the agar 
disc diffusion technique (Okore, 2005). The 
extract was diluted in DMSO to obtain 200 
mg/ml and 100 mg/ml of the extract. 
Thereafter, 0.02 ml amounts each were 
pipetted and spotted on a pre-made sterile 
filter paper discs. Nutrient agar in Petri- dish 
were prepared and dried in incubator for 30 
minutes at 37 oC. The under of the plates were 
divided into portions. A standardized 
suspension of an 18 hour growing test 
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organism was spread on the surface of the 
plates using a sterile cotton swab. The plates 
were rotated while swabbing to ensure even 
application. Thereafter, the antibiotics discs 
were then aseptically applied on the surface of 
the agar plates. Control discs containing 
DMSO alone was employed. This was done 
for the 10 isolates of each test bacteria. The 
plates were incubated at 37 oC for 24 hour and 
the observed growth inhibition zones were 
recorded and mean calculated. 
 
Antimicrobial sensitivity and minimum 
inhibitory concentration (MIC) 
determination 
The minimum inhibitory concentration 
(MIC) of Triumfetta rhomboidea extract 
against the different isolates employed in the 
study were determined using the agar 
diffusion technique (Okore, 2005). Briefly, 
serial concentrations of the methanol extract 
(12.5, 25, 50 and 100 mg/ml) were prepared in 
DMSO. This solution was introduced into 
equidistant wells of 6 mm bored on the 
surface of nutrient agar seeded with the 
laboratory isolates of test organisms. Blank 
DMSO were also placed in separate wells and 
served as controls. The plates were incubated 
at 37 °C for 24 h after a pre-diffusion period 
of 30 min at room temperature. Inhibition 
zone diameter were measured and recorded 
and MIC determined graphically.  
 
Interactions of the crude extract with the 
antibiotics   
A modified agar dilution and diffusion 
procedure was employed. Briefly, a 100 
mg/ml in DMSO of the plant extract was 
prepared and mixed with 20 ml of molten 
nutrient agar. This was poured in an agar plate 
and allowed to solidify to form the base 
antimicrobial agar. The standardized test 
bacteria already prepared was streaked on the 
surface of this plant extract agar base using a 
swab stick. Antibiotic discs were also placed 
on the plate. This evaluation was done for the 
Klebsiella pneumoniae and Salmonella typhi 
isolates. Two controls, one containing only 
the base agar with the plant extract and 
streaked microorganisms, and the other 
containing the base agar (without the plant 
extract) with the streaked microorganisms and 
over-layed with antibiotics discs were also 
employed in the study. All these plates were 
incubated at 37 oC for 18 – 24 hours. Growth 
in control A is a confirmation that the 
organism is not inhibited in the presence of 
the plant extract. The formation of zone of 
inhibition around the antibiotic discs in 
control B was employed in determining the 
activities of the disc antibiotics (Okore, 2005). 
 
Data treatment 
All experiments were done in replicates 
and mean of triplicate determinations 
established. The standard error of mean 
(SEM) were determined.  
 
RESULTS 
One (1) isolate each of S. aureus and S. 
typhi were sensitive at 200 mg/ml. However, 
for K. pneumoniae, six (6) of its isolates were 
slightly sensitive to the crude extract (100 
mg/ml) (Table 1). Result of the minimum 
inhibitory concentration (MIC) recorded for 
some of the isolates are displayed in Figure 1. 
The MICs were shown to be summarily less 
than or equal to 2 mg/ml except for isolate 1 
where it was not possible to establish 
susceptibility to the extract at other 
concentrations below 100 mg/ml . Table 2 
shows the basal susceptibility profile of K. 
pneumoniae towards commonly used standard 
antibiotics. All the isolates of K. pneumoniae 
showed susceptibility to one or more of the 
antibiotics except to amoxicillin, augmentin, 
and cotrimoxazole respectively. When T. 
rhomboideae was combined with the standard 
antibiotics against K. pneumoniae isolates, the 
effect ranged from antagonism to slight 
synergy (Table 3). The pattern of interaction 
was largely antimicrobial type-depended with 
variant behaviours displayed by individual 
antibiotics/crude extract cocktails. 
Phytochemical studies showed that the 
methanol extract contained terpenoids and 
flavonoids, carbohydrates, and other 
phenolics, but do not show positive for 
alkaloids, glycosides, and steroids (Table 4). 
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Table 1: Mean inhibition zone diameter (IZD) for crude extrac  gainst Klebsiella pneumoniae. 
 
Isolates Inhibition zone diameter (mm)  
1 2 ± 0.00 
2 7.5 ± 0.70 
3 8 ± 0.00 
4 9 ± 1.41 
5 9 ± 1.41 
6 - 10 0 ± 0.00 
The extract was tested at 100 mg/ml; Tabulated values are Mean ± SEM.
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Table 2: Mean inhibition zone diameter (IZD) for antibiotics against Klebsiella pneumoniae.  
 
 
Inhibition zone diameter (mm) / isolates  
Antibiotics 
1 2 3 4 5 6 7 8 9 10 
Nitrofurantoin 300 µg   11±0.00 21±1.41 24±0.00 22±1.41 21.5±0.70 20±0.00 15.5±0.70 20.5±0.70 21.5±2.12 - 
Gentamycin 10 µg  17±2.82 17.5±0.70 16.5±1.76 16.5±0.70 16.5±0.70  13±1.41 16.5±0.70 17±1.41 16±1.41 
Nalidixic acid 30 µg   22±0.00 28±0.00 20±0.00 23.5±0.70 31±1.41 + 16±0.00 + 24±1.41 20.5±0.70 
Ofloxacin 30 µg   34.5±0.70 30±0.00 32±0.00 31±1.41 31.5±0.70 + 31±1.41 20.5±0.70 32.5±2.12 31±1.41 
Tetracycline 30 µg  8.5±0.70 15.5±0.70 19±1.41 10.5± 70 14.5±0.70 + 15±0.00 8±0.00 15±0.00 - 




  Table 3: Mean inhibition zone diameter (IZD) for combined effect of crude extract  and antibiotics against Klebsiella pneumoniae.  
 
 
Inhibition zone diameter (mm) / isolates  
Antibiotics 
1 3 4 5 6 7 – 10 
Nitrofurantoin 300 µg   11±0.00 21.5±0.70 22.5±0.2.12 16±0.00 - 0±00 
Gentamycin 10 µg  10.5±0.70 - 7±0.70 7.5±0.70 7.5±0.70 0±00 
Nalidixic acid 30 mg   16±1.41 - 22±0.00 15±1.41 15.5±0.70 0±00 
Ofloxacin 30 µg   37±1.76 33.5±2.12 43±2.82 31±1.41 17±1.41 0±00 
Tetracycline 30 µg  - - 15±0.00 12.5±0.70 - 0±00 




C. D. ODIMEGWU et al. / Int. J. Biol. Chem. Sci. 5(5): 1970-1977, 2011 
 
 1975 
  Table 4: Phytochemical test of methanol extract of T. rhomboideae. 
 
Compound  Results 
Alkaloids  - 
Saponins  - 
Steroids  - 
Terpenes  ++ 
Phenolics  ++ 
Flavonoids  ++ 
Carbohydrates +++ 




The search for novel antimicrobial 
agents is usually driven by the need to provide 
newer generation of antibiotics to combat the 
increasingly growing threats posed by 
microorganisms and infections worldwide in 
the face of rapid decline of efficacy of older 
antimicrobial agents (Makanjuola, 2009). This 
growing antimicrobial drug-resistant 
evolutionary concern is also partly responsible 
for the adopted approach of combining two or 
more antimicrobial agents possessing average 
or a below-average efficacy as a therapeutic 
strategy to stem the unfavourable trend 
(Aguwa, 1996).  Research into newer 
antibiotics has involved several approaches 
including the evaluation of plant parts for 
possible antibiotics having previously yielded 
several useful antimicrobial agents (Cowan, 
1999; Iwu et al., 1999). Sometimes, the active 
principles isolated from the medicinal plant 
occupy a pivotal position as lead molecules 
for the synthesis of more active and useful 
agents by the pharmaceutical chemist (Cowan, 
1999).  
Our initial evaluation of the methanol 
extract of T. rhomboideae has shown that the 
crude extract was moderately inhibitory 
against clinical isolates of K. pneumoniae 
(Table 1). This recorded activity was equally 
observed to be dose-dependent as MIC values 
for some of the isolates were equal to or less 
than 2 mg/ml (Figure 1). Crude extracts are 
usually complex mixtures of 
chemical/biological constituents whose 
overall activity is a result of possible 
interaction of antagonistic, indifferent, and 
synergistic constituents (Odimegwu et al., 
2011). Further purification of crude extracts 
could possibly enhance the activity of 
individual constituents. On the other hand, 
given the potential benefit or non-benefit of 
administering combinations of two different 
antibiotics intentionally or unintentionally, we 
had the isolates profiled against the standard 
antibiotics (Table 2), and consequently 
proceeded to create interactive effect with the 
crude extract against the isolates. The result 
was a blend of relationships ranging from 
antagonism, indifference, and synergy (Table 
3). It is noteworthy, that the activities of the 
quinolone antibiotics (Ofloxacin, Norfloxacin, 
Nalidixic acid) with the crude extract were 
largely indifferent to a first approximation, 
except for Nalidixic acid that displayed 
obvious generalised antagonism.  However, a 
surprise candidate (isolate number 6) showing 
previously total resistances to the crude 
extract, nalidixic acid, and ofloxacin, 
gentamicin, and tetracycline respectively 
(Tables 2 and 3) suddenly became susceptible 
thereby defining an overt synergistic 
relationship. It is not known why this is so. A 
plausible explanation may be to assume that 
an inhibitory complex (possibly genetically 
disposed to by the isolate 6) possibly formed 
between the antibiotics and crude extract 
could be responsible for this. In the case of the 
aminoglycoside gentamicin, the outcome was 
consistent antagonism with some of the 
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isolates recording zero IZDs. Evaluation of 
antimicrobial combinations so as to define the 
nature of existing relationships apart from 
furnishing information on any possible 
modification of a potential plant-based 
antimicrobial lead molecule, could be of 
tremendous relevance in defining the pattern 
of biological effect of plant-based 
antimicrobial extracts and synthetic antibiotics 
when they are taken or administered 
concurrently especially in this era of herbal 
medicinal preparations boom. Another close 
observation of Table 3 could show that 
tetracycline recorded an overall antagonism 
with the crude extract. A bacteriostatic agent 
such as tetracycline, in the presence of multi-
biological cocktail of the crude extract may 
possibly encounter biological barrier-induced 
attenuation.  
So far, comparative analysis would 
show that while the widely utilised antibiotics 
cotrimoxazole, amoxicillin, and augmentin 
were totally ineffective against any single 
isolate, the crude extract recorded clear 
activity against six (6) of the ten (10) bacteria 
isolates. This outcome constitutes an 
encouraging boost for the crude extract, thus 
paving way for further studies on the plant. 
Moreover, the recorded antimicrobial 
activities against K. pneumoniae would 
equally demonstrate a good success-rating for 
the crude extract because of the evident 
crucial position occupied by the species as a 
biological compartment and an active 
disseminator of antimicrobial resistance 
determinants across various bacterial species 
and genera (Amita et al., 2003; Khadri et al., 
2007). Therefore, a plant-based antimicrobial 
with promising activity against Klebsiella spp 
could translate into a useful therapeutic 
missile with an ultimate far reaching benefit to 
the antimicrobial world.  
Finally, phytochemical analysis of the 
methanol extract could show the presence of 
terpenoids, phenolics, and flavonoids. It is 
therefore expected that one or all of these 
phytoconstituents could be responsible for the 
observed antimicrobial attributes. 
 
Conclusion 
At present, quite limited work has been 
carried on the antimicrobial potential of 
extracts of Triumfetta rhomboideae. It is 
expected that the useful outcome of this 
present study would consequently serve as a 
useful guide and basis for further evaluation 
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